US Stock MarketDetailed Quotes

TEVA Teva Pharmaceutical Industries

Watchlist
  • 16.500
  • -0.310-1.84%
Close Dec 13 16:00 ET
  • 16.500
  • 0.0000.00%
Post 20:01 ET
18.70BMarket Cap-19.41P/E (TTM)

About Teva Pharmaceutical Industries Company

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Company Profile

SymbolTEVA
Company NameTeva Pharmaceutical Industries
Listing DateMay 30, 2012
Founded1901
CEOMr. Richard D. Francis
MarketNYSE
Employees37851
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address124 Dvora HaNevi'a Street
CityTel Aviv
ProvinceTel Aviv
CountryIsrael
Zip Code6944020
Phone972-3-914-8213
Websitehttp://www.tevapharm.com

Company Executives

  • Name
  • Position
  • Salary
  • Richard D. Francis
  • Director, President and Chief Executive Officer
  • 25.71M
  • David R. McAvoy
  • Executive Vice President and Chief Legal Officer
  • --
  • Eli Kalif
  • Executive Vice President and Chief Financial Officer
  • 4.94M
  • Amir Weiss
  • Senior Vice President and Chief Accounting Officer
  • --
  • Eric A Hughes
  • Executive Vice President, Global R&D and Chief Medical Officer
  • --
  • Matthew Shields
  • Executive Vice President, Global Operations
  • --
  • Christine Fox
  • Executive Vice President, U.S. Commercial
  • --
  • Mark Sabag
  • Executive Vice President, International Markets Commercial
  • 3.73M
  • Angus Grant
  • Executive Vice President, Business Development
  • --
  • Richard Daniell
  • Executive Vice President, European Commercial
  • 5.16M
  • Dr. Sol J. Barer,PhD
  • Chairman of the Board
  • 539.99K
  • Rosemary A. Crane, M.B.A.
  • Independent Director
  • 330.00K
  • Amir Elstein
  • Independent Director
  • 340.00K
  • Dr. Perry D. Nisen
  • Independent Director
  • 327.87K
  • Dr. Tal Zaks, M.D.,PhD
  • Independent Director
  • 330.00K
  • Chen Lichtenstein
  • Independent Director
  • --
  • Gerald M. Lieberman
  • Independent Director
  • 355.00K
  • Roberto A. Mignone
  • Independent Director
  • 340.00K
  • Professor Ronit Satchi-Fainaro
  • Independent Director
  • 315.25K
  • Professor Varda Shalev
  • Independent Director
  • 176.66K
  • Janet S. Vergis
  • Independent Director
  • 325.46K
  • Vikki L. Conway
  • Acting Head of Global Human Resources
  • --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List

Investment Theme Infectious Disease
Infectious Disease
Intraday-0.04%